# A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation

> **NCT04223557** · NA · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 84 (actual)

## Conditions studied

- Visceral Obesity
- Ultrasound Therapy
- Dyslipidemias

## Interventions

- **DEVICE:** focused power ultrasound treatment
- **DEVICE:** Sham treatment

## Key facts

- **NCT ID:** NCT04223557
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-30
- **Primary completion:** 2021-07-08
- **Final completion:** 2021-12-31
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223557, "A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04223557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*